{
}
UBS has maintained a "Buy" rating for McDonald's, setting a price target of $345. Analyst Dennis Geiger noted uncertainty regarding the impact of recent E. coli cases on the fast-food chain's revenue, but expects McDonald's to respond proactively to the risks.
UBS has maintained a "Neutral" rating for Roche, setting a target price of 270 francs. Analyst Matthew Weston noted that the pharmaceutical company's third-quarter performance slightly exceeded expectations, with growth drivers remaining on track.
UBS has maintained its "Buy" rating for Iberdrola, setting a target price of 15.30 euros. Analyst Gonzalo Sanchez-Bordona noted that the utility's third-quarter performance exceeded expectations, particularly in net profit.
UBS has maintained its "Buy" rating for Merck KGaA, setting a target price of 190 euros. This decision follows the company's capital markets day, which reinforced the analyst's positive view on the stock's attractive valuation, according to analyst Matthew Weston.
UBS has reduced its price target for L'Oréal from 415 to 409 euros following disappointing third-quarter sales figures, maintaining a "Neutral" rating. Analyst Guillaume Delmas noted that the personal care group's comparable revenue growth fell short of expectations.
UBS has maintained its "Buy" rating for Totalenergies, setting a target price of 67 euros. Analyst Henri Patricot noted that the company's recent strategy, particularly regarding its liquefied natural gas business, has improved the risk/reward ratio, indicating a more favorable outlook.
UBS has maintained a "Neutral" rating for Givaudan, setting a price target of 4,520 francs following an investor event focused on the fragrance business. Analyst Charles Eden noted ongoing discussions regarding the anticipated slowdown in growth within this segment and its potential impact on profitability.
UBS has maintained a "Buy" rating for Munich Re, setting a target price of 565 euros following the third-quarter results. Despite a weaker-than-expected profit, analyst Will Hardcastle anticipates only a cautious negative market reaction and does not foresee significant adjustments to the reinsurer's estimates.
UBS has maintained a "Neutral" rating for Salzgitter AG, setting a target price of 17 euros. The steel and tubes manufacturer has issued another profit warning, indicating potential downside for the 2025 estimates, according to analyst Andrew Jones.
UBS has increased its price target for Sartorius Stedim Biotech from 194 to 215 euros following the release of third-quarter figures, maintaining a "Neutral" rating. Analyst Matthew Weston attributed the adjustment to generally higher valuations within the biotechnology sector.
Hubert Dichtl
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
UBS maintains buy rating for McDonald's amid E. coli concerns
United States Dollar
McDonald's Corporation
CHE
USA
Hubert Dichtl
Dennis Geiger
Thomas Müller
Show more
11:37 23.10.2024
UBS maintains neutral rating for Roche with target price of 270 francs
11:31 23.10.2024
UBS maintains buy rating for Iberdrola with target price of 15.30 euros
11:11 23.10.2024
UBS maintains buy rating for Merck KGaA with target price of 190 euros
10:14 23.10.2024
UBS lowers L'Oreal price target to 409 euros maintains neutral rating
10:13 23.10.2024
UBS maintains buy rating for Totalenergies with target price of 67 euros
07:11 23.10.2024
UBS maintains neutral rating for Givaudan amid fragrance business concerns
07:07 23.10.2024
UBS maintains buy rating for Munich Re with target price of 565 euros
14:58 22.10.2024
UBS maintains neutral rating for Salzgitter with profit warning issued
14:57 22.10.2024
UBS raises price target for Sartorius Stedim Biotech to 215 euros
Euro
Sartorius Stedim Biotech S.A.
CHE
DEU
Warren Buffet
Matthew Weston
Hubert Dichtl
Thomas Müller
Show more
09:56 22.10.2024
Trending
Subcategory
Startups & Entrepreneurship
Industry Trends
Corporate News
Private Equity Deals
Retail and Consumer Goods
Supply Chain Management
Global Trade Developments
CEO Changes
Government Economic Policies
Corporate Social Responsibility
Industry Mergers & Acquisitions
Workplace Trends
Energy Sector Developments
Venture Capital Investments
Fintech Startups
Finance Mergers & Acquisitions
AI Innovations
Market Analysis and Predictions
Intellectual Property Laws
Central Bank Actions
Countries:
Companies:
Apple Inc.
NVIDIA Corporation
Google Inc.
Amazon.com, Inc.
Tesla, Inc.
Salesforce, Inc.
Garuda Aerospace Ltd.
Huawei Technologies CO. Ltd.
Bharti Airtel Ltd.
XPeng Inc.
Microsoft Corporation
Venturewave Capital NO.1 Ltd.
Semler Scientific, Inc.
TENCENT
Wipro Ltd
OpenAI ERC USD
Orange S.A.
IDBI Bank Limited
Standard Chartered Bank
LENOVO GROUP
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Saudi Riyal
Japanese Yen
Malaysian Ringgit
British Pound Sterling
Mexican Peso
Brazilian Real
New Taiwan Dollar
Bahraini Dinar
Qatari Riyal
Pakistani Rupee
Kuwaiti Dinar
Vietnamese Đồng
South Korean Won
Algerian Dinar
People:
Donald Trump
Mark Zuckerberg
Bisrat Degefa
He Xiaopeng
Abdel Fattah El-Sisi
Anmol Singh Jaggi
Puneet Singh Jaggi
Sari Sabban
David Watkins
Simon Moon
Anas Algahtani
Matt Jones
Ayman Hamdan
Elon Musk
Allen Law
Xi Jinping
Anwar Hussain
Sultan Ibrahim ibni Sultan Iskandar
Prashant Joshi
Albinder Dhindsa